Safely Reduce Cystoscopic Evaluations for Hematuria Patients

Recruiting now · Not applicable

Conditions studied: Hematuria, Urothelial Neoplasm, Urothelial Carcinoma, Bladder Cancer

In brief

The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.

Key facts

Study ID

NCT06026189

Run by

Erasmus Medical Center

People needed

1100

Starts

2023-05-31

Expected to finish

2027-05-31

Last updated by the study team

2023-09-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Microscopically confirmed microscopic hematuria of voided urine defined as ≥3 erythrocytes per high power field
• Male patients ≥40 years
• Female patients ≥50 years

You may not qualify if…

• History of urothelial bladder- or urinary tract cancer
• Presence of macroscopic (visible) hematuria
• Woman who is or may be pregnant

Where it is running

• SeARCH-trial Pijpers — Rotterdam, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.